한글목차

하이드로겔 기반 DDS 시스템의 동향과 예측

세계의 하이드로겔 기반 DDS(약물 전달) 시스템 시장은 2024년부터 2030년까지의 복합 연간 성장률(CAGR) 6.8%를 나타낼 전망이며 2030년까지 추정 112억 달러에 이를 것으로 예측됩니다. 이 시장의 주요 촉진요인은 약물전달 시스템의 R&D 투자 증가와 약물전달 시스템의 방출 제어에 대한 수요 증가입니다. 세계의 하이드로겔 기반 DDS 시스템 시장의 미래는 피하, 눈, 구강의 각 시장에서의 기회에 의해 유망시되고 있습니다.

하이드로겔 기반 DDS 시스템(부문별)

본 보고서에서는 세계의 하이드로겔 기반 DDS 시스템에 대해 폴리머 원료별, 전달 경로별, 지역별 예측을 제공합니다.

하이드로겔 기반 DDS 시스템 시장 인사이트

Lucintel사의 예측에 의하면, 하이드로겔은 세포 접착 특성에 있어서 유리한 특성을 나타내기 때문에 예측 기간중, 천연 원료가 최대의 부문인 것을 계속한다고 합니다.

이 시장에서 눈은 가장 큰 부문으로 계속 될 것입니다.

북미는 현대의 치료비를 포괄하는 효과적인 상환이 가능하기 때문에 예측기간 동안에도 최대 지역으로 남을 것입니다.

FAQ

Q1. 시장 규모는 :

A1. 하이드로겔 기반 DDS 시스템 시장은 2030년까지 예상 112억 달러에 이를 것으로 예상됩니다.

Q2. 시장 성장 예측은 :

A2. 하이드로겔 기반 DDS 시스템 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 6.8%로 성장할 것으로 예측됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 :

A3. 이 시장의 주요 촉진요인은 약물전달 시스템의 연구 개발에 대한 투자 증가와 약물전달 시스템의 방출 제어에 대한 수요가 증가하고 있습니다.

Q4. 시장의 주요 부문은 :

A4. 하이드로겔 기반 DDS 시스템 시장의 미래는 피하, 눈, 구강의 각 시장에서의 기회에 의해 유망시되고 있습니다.

Q5. 시장의 주요 기업은 :

A5. 하이드로겔 기반 DDS 시스템 주요 기업은 다음과 같습니다.

• Galderma
• Blairex Laboratories
• Johnson & Johnson
• Bausch and Lomb
• Medtronic
• Ocular Therapeutix
• Ferring
• Endo International
• Akorn
• Tolmar Pharmaceuticals

Q6. 앞으로 가장 큰 시장 부문은 :

A6. Lucintel사는 천연 원료가 세포 접착 특성에서 유리한 특성을 나타내기 때문에 예측 기간 동안에도 최대 부문인 것을 계속할 것으로 예측했습니다.

Q7. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은:

A7. 북미는 현대 치료비를 포괄하는 효과적인 상환이 가능하기 때문에 예측기간 중 가장 규모가 큰 지역으로 지속될 전망입니다.

Q8. 보고서 사용자 정의는 가능한가?

A8. 그렇습니다, Lucintel는 추가 비용 없이 10% 주문을 받아서 만듭니다.

목차

제1장 주요 요약

제2장 세계의 하이드로겔 기반 DDS 시스템 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018년-2030년)

• 거시경제 동향(2018년-2023년)과 예측(2024년-2030년)
• 세계의 하이드로겔 기반 DDS 시스템 시장 동향(2018년-2023년)과 예측(2024년-2030년)
• 폴리머 원료별 하이드로겔 기반 DDS 시스템 시장
  • 천연
  • 합성
  • 하이브리드
• 전달 경로별 하이드로겔 기반 DDS 시스템 시장
  • 피하
  • 안과
  • 구강
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018년-2023년)

• 지역별 하이드로겔 기반 DDS 시스템 시장
• 북미의 하이드로겔 기반 DDS 시스템 시장
• 유럽의 하이드로겔 기반 DDS 시스템 시장
• 아시아태평양의 하이드로겔 기반 DDS 시스템 시장
• 기타 지역 하이드로겔 기반 DDS 시스템 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 폴리머 원료별 세계의 하이드로겔 기반 DDS 시스템 시장의 성장 기회
  • 전달 경로별 하이드로겔 기반 DDS 시스템 시장의 성장 기회
  • 지역별 세계의 하이드로겔 기반 DDS 시스템 시장의 성장 기회
• 세계의 하이드로겔 기반 DDS 시스템 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 하이드로겔 기반 DDS 시스템 시장의 능력 확대
  • 세계의 하이드로겔 기반 DDS 시스템 시장에 있어서의 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• Galderma
• Blairex Laboratories
• Johnson & Johnson
• Bausch and Lomb
• Medtronic
• Ocular Therapeutix
• Ferring
• Endo International
• Akorn
• Tolmar Pharmaceuticals

영문목차

Hydrogel-Based Drug Delivery System Trends and Forecast

The future of the global hydrogel-based drug delivery system market looks promising with opportunities in the subcutaneous, ocular, and oral cavity markets. The global hydrogel-based drug delivery system market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing investment in research and development for drug delivery systems and growing demand for controlled release of drug delivery systems.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hydrogel-Based Drug Delivery System by Segment

The study includes a forecast for the global hydrogel-based drug delivery system by polymer origin, route, and region.

Hydrogel-Based Drug Delivery System Market by Polymer Origin [Shipment Analysis by Value from 2018 to 2030]:

• Natural
• Synthetic
• Hybrid

Hydrogel-Based Drug Delivery System Market by Route [Shipment Analysis by Value from 2018 to 2030]:

• Subcutaneous
• Ocular
• Oral Cavity
• Others

Hydrogel-Based Drug Delivery System Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Hydrogel-Based Drug Delivery System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hydrogel-based drug delivery system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hydrogel-based drug delivery system companies profiled in this report include-

• Galderma
• Blairex Laboratories
• Johnson & Johnson
• Bausch and Lomb
• Medtronic
• Ocular Therapeutix
• Ferring
• Endo International
• Akorn
• Tolmar Pharmaceuticals

Hydrogel-Based Drug Delivery System Market Insights

Lucintel forecasts that natural will remain the largest segment over the forecast period as they exhibit favorable traits for cell adhesion properties.

Within this market, ocular will remain the largest segment.

North America will remain the largest region over the forecast period due to availability of effective reimbursement that encompasses the costs of contemporary treatments.

Features of the Global Hydrogel-Based Drug Delivery System Market

Market Size Estimates: Hydrogel-based drug delivery system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hydrogel-based drug delivery system market size by polymer origin, route, and region in terms of value ($B).

Regional Analysis: Hydrogel-based drug delivery system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different polymer origin, routes, and regions for the hydrogel-based drug delivery system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hydrogel-based drug delivery system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hydrogel-based drug delivery system market size?

Answer: The global hydrogel-based drug delivery system market is expected to reach an estimated $11.2 billion by 2030.

Q2. What is the growth forecast for hydrogel-based drug delivery system market?

Answer: The global hydrogel-based drug delivery system market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hydrogel-based drug delivery system market?

Answer: The major drivers for this market are increasing investment in research and development for drug delivery systems and growing demand for controlled release of drug delivery systems.

Q4. What are the major segments for hydrogel-based drug delivery system market?

Answer: The future of the hydrogel-based drug delivery system market looks promising with opportunities in the subcutaneous, ocular, and oral cavity markets.

Q5. Who are the key hydrogel-based drug delivery system market companies?

Answer: Some of the key hydrogel-based drug delivery system companies are as follows:

• Galderma
• Blairex Laboratories
• Johnson & Johnson
• Bausch and Lomb
• Medtronic
• Ocular Therapeutix
• Ferring
• Endo International
• Akorn
• Tolmar Pharmaceuticals

Q6. Which hydrogel-based drug delivery system market segment will be the largest in future?

Answer: Lucintel forecasts that natural will remain the largest segment over the forecast period as they exhibit favorable traits for cell adhesion properties.

Q7. In hydrogel-based drug delivery system market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of effective reimbursement that encompasses the costs of contemporary treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hydrogel-based drug delivery system market by polymer origin (natural, synthetic, and hybrid), route (subcutaneous, ocular, oral cavity, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hydrogel-Based Drug Delivery System Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Hydrogel-Based Drug Delivery System Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Hydrogel-Based Drug Delivery System Market by Polymer Origin
  • 3.3.1: Natural
  • 3.3.2: Synthetic
  • 3.3.3: Hybrid
• 3.4: Global Hydrogel-Based Drug Delivery System Market by Route
  • 3.4.1: Subcutaneous
  • 3.4.2: Ocular
  • 3.4.3: Oral Cavity
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Hydrogel-Based Drug Delivery System Market by Region
• 4.2: North American Hydrogel-Based Drug Delivery System Market
  • 4.2.1: North American Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
  • 4.2.2: North American Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
• 4.3: European Hydrogel-Based Drug Delivery System Market
  • 4.3.1: European Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
  • 4.3.2: European Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
• 4.4: APAC Hydrogel-Based Drug Delivery System Market
  • 4.4.1: APAC Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
  • 4.4.2: APAC Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
• 4.5: ROW Hydrogel-Based Drug Delivery System Market
  • 4.5.1: ROW Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
  • 4.5.2: ROW Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Polymer Origin
  • 6.1.2: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Route
  • 6.1.3: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Region
• 6.2: Emerging Trends in the Global Hydrogel-Based Drug Delivery System Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Hydrogel-Based Drug Delivery System Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hydrogel-Based Drug Delivery System Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Galderma
• 7.2: Blairex Laboratories
• 7.3: Johnson & Johnson
• 7.4: Bausch and Lomb
• 7.5: Medtronic
• 7.6: Ocular Therapeutix
• 7.7: Ferring
• 7.8: Endo International
• 7.9: Akorn
• 7.10: Tolmar Pharmaceuticals